Biomarker role of maternal soluble human leukocyte antigen G in pre‐eclampsia: A meta‐analysis
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1254 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Abhinav Bhattarai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Tribhuvan University, Maharajgunj, Nepal. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Human leukocyte antigen‐G (HLA‐G) is a non‐classical class I HLA molecule shown to regulate the immunomodulation of maternal immune cells to prevent fetal tissue destruction. Low levels of freely circulating maternal soluble HLA‐G (sHLA‐G) have been observed in pre‐eclampsia, however, no pooled evidence exists. This meta‐analysis aimed to generate pooled findings on the association of sHLA‐G levels with pre‐eclampsia and is the first study to perform a trimester‐wise comparison of the levels of sHLA‐G in preeclamptic cases and normal pregnant controls.
Methods
The databases PubMed, Emba, Web of Science, and Google Scholar through May 31, 2023. Preeclamptic women were defined as cases and normal pregnancies as controls. Data on the level of sHLA‐G in cases and controls was extracted and subjected to a meta‐analysis using a random‐effects model. The pooled effect was expressed in terms of standardized mean difference (SMD). Sensitivity analysis was performed to investigate the effect of the exclusion of each study on the pooled results. Publication bias was assessed statistically.
Results
Nine studies with altogether 567 PE cases and 1132 normal pregnancy controls were included in the meta‐analysis. The first and third trimester levels of sHLA‐G in PE cases were significantly lower than that of normal pregnant controls: (SMD: −0.84 [−1.29; −0.38]; p = .003; I 2 = 54%) and (SMD: −0.39 [−0.71; −0.06]; p = .02; I 2 = 79%) respectively. Sensitivity analysis revealed significant fluctuations in the pooled findings when few studies were excluded, raising questions on the consistency of results among studies.
Conclusion
Although we found that first and third‐trimester sHLA‐G levels in pre‐eclampsia are significantly lower, taking into consideration the inconsistent results from the sensitivity analysis, our findings advocate the demand for more studies with larger sample sizes to generate solid ground pooled evidence on the predictive role of sHLA‐G in pre‐eclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicine, Tribhuvan University, Maharajgunj, Nepal.
- Department of Neurology, Westchester Medical Center, Valhalla, New York, USA.
- Rochester General Hospital, Rochester, New York, USA.
- Vicerrectorado de Investigacion, Universidad Norbert Wiener, Lima, Peru.
- Department of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
- Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, India.
ORCID-Profile: Sangam Shah, Krishna Dahal, Ranjit Sah
Zitieren
APA
Bhattarai, A., Shah, S., Dahal, K., Neupane, R., Thapa, S., Neupane, N., Barboza, J. J., Shrestha, A., Sah, R., & Apostolopoulos, V. (2024). Biomarker role of maternal soluble human leukocyte antigen G in pre‐eclampsia: A meta‐analysis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1254
Vancouver
Bhattarai A, Shah S, Dahal K, Neupane R, Thapa S, Neupane N, et al. Biomarker role of maternal soluble human leukocyte antigen G in pre‐eclampsia: A meta‐analysis. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1254
BibTeX
@article{Bhattarai2024,
author = {Bhattarai, Abhinav and Shah, Sangam and Dahal, Krishna and Neupane, Raksha and Thapa, Sangharsha and Neupane, Niraj and Barboza, Joshuan J and Shrestha, Anisha and Sah, Ranjit and Apostolopoulos, Vasso},
title = {Biomarker role of maternal soluble human leukocyte antigen G in pre‐eclampsia: A meta‐analysis},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1254}
}
EUVIMED